The therapeutic exploitation of P2X7 receptors is now under way because of their potential role, not only in such disorders as AD, spinal cord injury, and sensory neuropathies [137] but also in multiple sclerosis [138], inflammatory neuropathic pain [36], rheumatoid arthritis [35], as well as depressive illness. This evidence concerns the gene P2RX7 and sensory peripheral neuropathy.